Lochner Daniel — SEC insider filings
SEC reporting owner CIK 1791187. 23 insider filings on record with FilingPulse; latest filed 2026-10-02.
Transaction summary — filings shown
Covers all 23 filings on record, filed 2020-08-12 to 2026-10-02. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): 2 legs across 2 filings — 10,617 shares, $379,624 total (shares × price as filed).
- Open-market sales (code S, non-derivative): none reported.
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 40.
- Largest priced transaction: purchase of 4,617 shares @ $54.14 ($249,964) in Tectonic Therapeutic, Inc., filed 2025-02-07.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Tectonic Therapeutic, Inc. (TECX) | Chief Financial Officer | 10 | 2 legs · 10,617 sh · $379,624 | — | 11 |
| Oyster Point Pharma, Inc. (OYST) | Chief Financial Officer | 13 | — | — | 29 |
Insider filings — Lochner Daniel
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-10-02 | 4 | Tectonic Therapeutic, Inc. (TECX) | Tax withholding (F): 520 @ $23.67 | EDGAR |
| 2026-09-08 | 4 | Tectonic Therapeutic, Inc. (TECX) | Grant/award (A): 24,250 (derivative) @ $0 | EDGAR |
| 2026-06-12 | 4 | Tectonic Therapeutic, Inc. (TECX) | Grant/award (A): 7,500 (derivative) @ $0 | EDGAR |
| 2026-03-05 | 4 | Tectonic Therapeutic, Inc. (TECX) | Grant/award (A): 26,500 @ $0 · Grant/award (A): 24,250 (derivative) @ $0 | EDGAR |
| 2026-02-11 | 4 | Tectonic Therapeutic, Inc. (TECX) | Purchase (P): 6,000 @ $21.61 | EDGAR |
| 2026-02-10 | 4 | Tectonic Therapeutic, Inc. (TECX) | Tax withholding (F): 2,077 @ $23.22 | EDGAR |
| 2025-09-29 | 4 | Tectonic Therapeutic, Inc. (TECX) | Grant/award (A): 5,430 @ $0 · Grant/award (A): 9,860 (derivative) @ $0 | EDGAR |
| 2025-02-07 | 4 | Tectonic Therapeutic, Inc. (TECX) | Purchase (P): 4,617 @ $54.14 | EDGAR |
| 2025-02-06 | 4 | Tectonic Therapeutic, Inc. (TECX) | Grant/award (A): 18,074 @ $0 · Grant/award (A): 32,862 (derivative) @ $0 | EDGAR |
| 2024-06-24 | 4 | Tectonic Therapeutic, Inc. (TECX) | Grant/award (A): 118,000 (derivative) @ $0 | EDGAR |
| 2023-01-04 | 4 | Oyster Point Pharma, Inc. (OYST) | Tax withholding (F): 938 @ $11.70 · Code (U): 56,289 · Disposition to issuer (D): 20,236 · Disposition to issuer (D): 300,000 (derivative) · Disposition to issuer (D): 161,251 (derivative) · Disposition to issuer (D): 72,648 (derivative) · +3 more | EDGAR |
| 2022-12-06 | 4 | Oyster Point Pharma, Inc. (OYST) | Tax withholding (F): 3,258 @ $11.20 | EDGAR |
| 2022-07-08 | 4 | Oyster Point Pharma, Inc. (OYST) | Grant/award (A): 300,000 (derivative) @ $0 | EDGAR |
| 2022-01-11 | 4 | Oyster Point Pharma, Inc. (OYST) | Grant/award (A): 19,500 @ $0 · Grant/award (A): 87,900 (derivative) @ $0 | EDGAR |
| 2021-11-02 | 4 | Oyster Point Pharma, Inc. (OYST) | Option exercise (M): 8,590 @ $11.51 · Option exercise (M): 8,590 (derivative) @ $0 | EDGAR |
| 2021-09-07 | 4 | Oyster Point Pharma, Inc. (OYST) | Option exercise (M): 7,500 @ $11.51 · Option exercise (M): 7,500 (derivative) @ $0 | EDGAR |
| 2021-08-30 | 4 | Oyster Point Pharma, Inc. (OYST) | Grant/award (A): 45,000 (derivative) @ $0 | EDGAR |
| 2021-07-29 | 4 | Oyster Point Pharma, Inc. (OYST) | Option exercise (M): 7,500 @ $11.51 · Option exercise (M): 7,500 (derivative) @ $0 | EDGAR |
| 2021-02-26 | 4 | Oyster Point Pharma, Inc. (OYST) | Option exercise (M): 9,109 @ $11.51 · Option exercise (M): 9,109 (derivative) @ $0 | EDGAR |
| 2021-02-02 | 4 | Oyster Point Pharma, Inc. (OYST) | Grant/award (A): 11,222 @ $0 · Grant/award (A): 50,500 (derivative) @ $0 | EDGAR |
| 2020-09-28 | 4 | Oyster Point Pharma, Inc. (OYST) | Option exercise (M): 4,000 @ $11.51 · Option exercise (M): 4,000 (derivative) @ $0 | EDGAR |
| 2020-08-18 | 4/A | Oyster Point Pharma, Inc. (OYST) | Option exercise (M): 4,000 @ $11.51 | EDGAR |
| 2020-08-12 | 4 | Oyster Point Pharma, Inc. (OYST) | Option exercise (M): 4,000 @ $11.51 · Option exercise (M): 4,000 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2020-08-10 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1791187 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs